{
  "retracted": false,
  "timestamp": 1592438400000,
  "updates": [
    {
      "timestamp": 1592484024713,
      "identifier": {
        "doi": "10.1038/s41591-020-0978-1"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1038/s41591-020-0918-0"
  },
  "journal": "Nature Medicine",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis"
}
